GLP-1 medications primarily address biological hunger and satiety mechanisms but do not directly target learned eating behaviors or emotional connections to food
By considering weight stability, health status, lifestyle habits, and personal preferences, your healthcare providers can help guide you through a safe and effective transition
Wegovy (semaglutide) is an injectable GLP-1 (glucagon-like peptide-1) medication that was initially approved by the Food and Drug Administration (FDA) for weight loss along with lifestyle changes like diet and exercise
About the Experts Vishwanath Venketaraman, Ph.D., is a professor of microbiology and immunology at the Western University of Health Sciences in Pomona, CA
Support your peptide protocol with an anti-inflammatory diet rich in omega-3 fatty acids (fatty fish, walnuts, flaxseed), polyphenols (berries, green tea, dark chocolate), and prebiotic fiber (garlic, onions, asparagus)
Appetite suppression may begin as early as the first injection for some users, while others notice minimal effect until they reach higher doses